McKinley Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-54,216	Closed	-$5.21M	–	197
2020 Q3	$5.21M	Sell	54,216 -99,884	-65%	-$11.6M	0.41%	71
2020 Q2	$18.8M	Sell	154,100 -6,169	-4%	-$682K	1.28%	23
2020 Q1	$13.9M	Sell	160,269 -1,492	-0.9%	-$146K	1.11%	32
2019 Q4	$17.4M	Buy	161,761 +28,393	+21%	+$2.97M	1.13%	34
2019 Q3	$12M	Sell	133,368 -13,617	-9%	-$1.27M	0.9%	46
2019 Q2	$12.4M	Sell	146,985 -29,403	-17%	-$2.41M	0.79%	44
2019 Q1	$15.5M	Buy	176,388 +3,710	+2%	+$310K	1.12%	33
2018 Q4	$12.3M	Sell	172,678 -2,782	-2%	-$267K	1%	37
2018 Q3	$21.6M	Buy	175,460 +48,562	+38%	+$5.51M	1.37%	28
2018 Q2	$12.5M	Buy	126,898 +1,833	+1%	+$164K	0.81%	45
2018 Q1	$10.4M	Sell	125,065 -13,759	-10%	-$1.16M	0.61%	56
2017 Q4	$10.8M	Buy	+138,824	New	+$9.47M	0.54%	57